These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder. Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY. Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419 [Abstract] [Full Text] [Related]
3. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, Rao H. Diagn Pathol; 2019 Jul 17; 14(1):82. PubMed ID: 31315684 [Abstract] [Full Text] [Related]
4. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation. Chen CC, Chang KC, Medeiros LJ, Lee JY. J Cutan Pathol; 2016 Dec 17; 43(12):1102-1111. PubMed ID: 27531667 [Abstract] [Full Text] [Related]
6. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases. Zhang Y, Liu Y, Xu J, Liang Y, Xu Z. Eur J Dermatol; 2024 Apr 01; 34(2):144-149. PubMed ID: 38907544 [Abstract] [Full Text] [Related]
7. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection. Heo EP, Park SH, Kim TH. Int J Dermatol; 2003 Jun 01; 42(6):476-9. PubMed ID: 12854510 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, Lee SK, Suh DH, Chung JH, Yoon TY, Lee SJ. Br J Dermatol; 2004 Aug 01; 151(2):372-80. PubMed ID: 15327544 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children. Xu Z, Lian S. Pediatr Dermatol; 2010 Aug 01; 27(5):463-9. PubMed ID: 20497358 [Abstract] [Full Text] [Related]
11. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy. Hirai Y, Asada H, Hamada T, Kawada JI, Kimura H, Arai A, Ohshima K, Ohga S, Iwatsuki K, Committee for Guidelines for the Management of Chronic Active EBV Disease and Related Disorders (the MHLW Research Team in Japan). J Dermatol; 2023 Jul 01; 50(7):e198-e205. PubMed ID: 37249004 [Abstract] [Full Text] [Related]
13. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M. J Dermatol; 2021 Sep 01; 48(9):1315-1326. PubMed ID: 33982815 [Abstract] [Full Text] [Related]